Papers

First author

• Understanding the complex pharmacology of cannabidiol: mounting evidence suggests a common binding site with cholesterol, 2021 Pharmacol. Res.
• Comparing Fingerprints for Ligand-Based Virtual Screening: A Fast and Scalable Approach for Unbiased Evaluation, 2020 JCIM
• Electric fields control the orientation of peptides irreversibly immobilized on radical-functionalized surfaces, 2018 Nat. Commun.
• Force fields for simulating the interaction of surfaces with biological molecules, 2016 Interface Focus
• Locating the route of entry and binding sites of benzocaine and phenytoin in a bacterial voltage gated sodium channel, 2014 PLoS Comput. Biol.
• Molecular dynamics simulation of the partitioning of benzocaine and phenytoin into a lipid bilayer, 2014 Biophys. Chem.

Not first author

• Exploring Stereochemical and Conformational Requirements at Cannabinoid Receptors for Synthetic Cannabinoids Related to SDB-006, 5F-SDB-006, CUMYL-PICA, and 5F-CUMYL-PICA, 2020 ACS Chem. Neurosci.
• Divergent pathways mediate 5-HT1A receptor agonist effects on close social interaction, grooming and aggressive behaviour in mice: Exploring the involvement of the oxytocin and vasopressin systems, 2020 J. Psychopharmacol.
• Medicinal Cannabis for Inflammatory Bowel Disease: A Survey of Perspectives, Experiences, and Current Use in Australian Patients, 2020 Crohn’s & Colitis 360
• Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions, 2019 Epilepsia
• The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F‐PY‐PICA, 5F‐PY‐PINACA, and their analogs, 2019 Drug Test. Anal.
• Plasma activated coatings with dual action against fungi and bacteria, 2018 Appl. Mater. Today